Horowitz: The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin

- THE BLAZE - DANIEL HOROWITZ - DEC 22, 2021 -

Rafael Henrique/SOPA Images/LightRocket/Getty Images

Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events. The approval is as shocking as it is revealing and should serve as a warning to those who don’t believe the FDA would approve vaccines that aren’t safe and effective.


We already know that every drug the FDA has approved so far for inpatient treatment has an FDA “black box warning” for serious adverse events. At present, the only approved drugs in-patient are remdesivir, baricitinib, and tofacitinib. None of them have demonstrated any efficacy over a year of their use, and remdesivir is known to cause liver toxicity and renal failure. Baricitinib (brand name Olumiant) has an FDA black box warning for blood clots, of all things! Tofacitinib (brand name Xeljanz) has a black box warning for “serious infections and malignancy.” Now, let me introduce you to the first candidates for outpatient treatment: Merck’s molnupiravir (brand name Lagevrio) and Pfizer’s Paxlovid.


I’ve already written extensively on molnupiravir. Even the FDA advisory committee admitted that the drug poses a risk of birth defects, is mutagenic, has a dangerous mechanism of action, and was never studied for carcinogenicity, and its second-phase trial showed greater “efficacy” in the placebo group than the trial group. Even the mainstream media has warned that the drug really is not up to snuff, yet shockingly, the FDA is set to give it approval, as if basic safety and efficacy facts no longer matter. This move in itself, in conjunction with what we know about the approved inpatient drugs, should tell you everything you need to know about the juxtaposition of the vaccine approval to the war on ivermectin and hydroxychloroquine and the refusal to approve or encourage the use of numerous other safe and effective drugs.


LEIA MAIS NO SITE >

https://www.theblaze.com/op-ed/horowitz-the-indefensible-approval-of-pfizer-and-merck-drugs-compared-to-the-snubbing-of-ivermectin?utm_source=theblaze-breaking&utm_medium=email&utm_campaign=20211222Trending-Horowitz&utm_term=ACTIVE%20LIST%20-%20TheBlaze%20Breaking%20News


Acesse a minha HOME PAGE, para assistir meus vídeos e ler meus livros: https://www.heitordepaola.online/


9 views0 comments